Abstract:OBJECTIVE:To investigate the relationship between neurokinin B (NKB), endothelin-1 (ET-1) and the pathogenesis of hypertensive disorder complicating pregnancy (HDCP). METHODS:22 HDCP, who received antenatal examination in the Department of Obstetrics and Gynecology of Union Hospital of Tongji Medical College in Huazhong University of Science and Technology from March to July in 2005, were selected for the study, including 12 gestational hypertension (gestational hypertension group) and 10 preeclampsia (preeclamptic group); 22 normal pregnant women in the same period were served as control. At different gestational weeks, maternal plasma levels of NKB and ET-1 in three groups were detected by enzyme-linked immunoassay technique, the expression and location of NKB in placenta were examined by immunohistochemical SP, and mRNA expressions of NKB and ET-1 in placenta were measured with RT-PCR method. RESULTS:(1) At 10 - 14, 20 - 24, and 30 - 34 gestational weeks, the plasma levels of NKB and ET-1 in preeclamptic group were (35.6 +/- 5.2), (17.9 +/- 4.3), (39.5 +/- 4.3), (22.7 +/- 3.6), (47.1 +/- 3.3) and (27.5 +/- 3.5) microg/L, respectively; in the control group they were (22.9 +/- 3.3), (10.7 +/- 5.3), (30.2 +/- 3.4), (13.2 +/- 4.1), (34.6 +/- 4.3) and (16.6 +/- 4.8) microg/L, respectively. There was a significant difference between preeclamptic group and control group (P < 0.05), while there was no significant difference between gestational hypertension group and control group (P > 0.05). (2) Immunohistochemical staining for NKB protein was observed in all groups and was located in the villous syncytiotrophoblast and villous vascular endothelial cells as well as cytoplasm of stromal cells, mostly located in villous syncytiotrophoblast. The expressions of NKB in placenta of preeclamptic group (0.244 +/- 0.020) was significantly higher than that in control group (0.160 +/- 0.012), with a significant difference between the two groups (P < 0.05). However, there was no significant difference between gestational hypertension group (0.162 +/- 0.019) and control group (P > 0.05). (3) The transcription levels of the NKB mRNA (0.97 +/- 0.36) and ET-1 mRNA (0.90 +/- 0.36) in preeclamptic placentas were both significantly higher than those in control groups (0.78 +/- 0.54, 0.65 +/- 0.47, respectively), with a significant difference between the two groups (P < 0.05). But there was no significant difference between gestational hypertension group (0.80 +/- 0.40, 0.70 +/- 0.32, respectively) and control group (P > 0.05). (4) There was an evident positive correlation between plasma NKB and ET-1 levels in preeclampsia (r = 0.79, P < 0.05). CONCLUSIONS:The significantly increased maternal plasma levels of NKB and ET-1 of patients with preeclampsia occur at early pregnancy (10 - 14 gestational weeks) before the onset of clinical symptoms. The change of maternal plasma levels of NKB and ET-1 is closely related to pathogenesis of HDCP.

Progress of SDF-1/CXCR4 and Hypertensive Disorder Complicating Pregnancy

The Relationship Between Expression of SDF-1/CXCR4 in Placenta and Development of Hypertensive Disorder Complicating Pregnancy

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Association between serum placental growth factor and vascular endothelial function in hyprtensive disorders complicating pregnancy

Research and Progression of Homocysteine and High Sensitivity C-reactive Protein in Hypertensive Disorders for Pregnancy

Expression of Interferon‐γ in Decidual Natural Killer Cells from Women with Hypertensive Disorder Complicating Pregnancy

Relationship between intercellular adhesion molecule-1 and the occurrence of hypertensive disorder complicating pregnancy

High expression of CX3CL1/CX3CR1 at the mother-fetus interface of preeclampsia inhibits trophoblast invasion and migration

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

[Relationship Between Neurokinin B and Endothelin-1 and Hypertensive Disorders Complicating Pregnancy].

Serum Macrophage Colony-Stimulating Factor Relates to the Severity and the Pregnancy Outcomes in Hypertensive Disorders Complicating Pregnancy

Placental Vascularization Alterations in Hypertensive Disorders Complicating Pregnancy (HDCP) and Small for Gestational Age with HDCP Using Three-Dimensional Power Doppler in a Prospective Case Control Study

Expression and Meaning of Placenta Tissue VCAM-1 in Hypertensive Disorders Complicating Pregnancy

Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy

Homocysteine, endothelin-1 and nitric oxide in patients with hypertensive disorders complicating pregnancy

Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus

A Systematic Review of the Molecular Mechanisms

Analysis of Placental Growth Factor in Placentas of Normal Pregnant Women and Women with Hypertensive Disorders of Pregnancy

Decrease And Dysfunction Of Endothelial Progenitor Cells In Umbilical Cord Blood With Maternal Pre-Eclampsia

The Maternal-Fetal Risk Factors of Hypertensive Disorders of Pregnancy and its Effects on Infant Complete Blood Count and Coagulation Factors

Exosomes from Women with Preeclampsia Induced Vascular Dysfunction by Delivering Sflt (soluble Fms-Like Tyrosine Kinase)-1 and Seng (soluble Endoglin) to Endothelial Cells